1 Min Read
* FILES FOR PATENT FOR ITS INVENTION ‘COMBINATION THERAPY OF MULTIPLE SCLEROSIS COMPRISING A CD20 LIGAND’ Source text for Eikon: Further company coverage: (Gdynia Newsroom)
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2018 Reuters. All Rights Reserved.